Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210496
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2005-09-13
Brief Title:
Potential Impact Benefit of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
Sponsor:
Janssen-Ortho LLC
Organization:
Janssen-Ortho LLC
Organization Data
Organization:
Janssen-Ortho LLC
Class:
INDUSTRY
Study ID:
CR002875
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen-Ortho LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Johnson Johnson Pharmaceutical Research Development LLC | INDUSTRY |